Expression of ASC in Renal Tissues of Familial Mediterranean Fever Patients with Amyloidosis: Postulating a Role for ASC in AA Type Amyloid Deposition

被引:29
|
作者
Balci-Peynircioglu, Banu [1 ,2 ]
Waite, Andrea L. [2 ]
Schaner, Philip [3 ]
Taskiran, Zihni Ekim [1 ]
Richards, Neil [2 ]
Orhan, Diclehan [4 ]
Gucer, Safak [4 ]
Ozen, Seza [5 ]
Gumucio, Deborah [2 ]
Yilmaz, Engin [1 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Med Biol, TR-06100 Ankara, Turkey
[2] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA
[3] Univ Alabama Birmingham, Div Radiol Oncol, Birmingham, AL 35294 USA
[4] Hacettepe Univ, Fac Med, Ihsan Dogramaci Childrens Hosp, Dept Child Hlth,Unit Pediat Pathol, TR-06100 Ankara, Turkey
[5] Hacettepe Univ, Fac Med, Ihsan Dogramaci Childrens Hosp, Dept Child Hlth,Nephrol & Rheumatol Unit, TR-06100 Ankara, Turkey
基金
美国国家卫生研究院;
关键词
ASC; amyloidosis; speck; microtubules;
D O I
10.3181/0803-RM-106
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Familial Mediterranean fever (FMF) is characterized by recurrent attacks of fever and serositis; in some cases, ensuing amyloidosis results in kidney damage. Treatment with colchicine reduces the frequency and severity of FMF attacks and prevents amyloidosis, although the mechanisms behind these effects are unknown. Pyrin, the protein product of the MEFV gene, interacts with ASC, a key molecule in apoptotic and inflammatory processes. ASC forms intracellular speck-like aggregates that presage cell death. Here we show that cell death after ASC speck formation is much slower in nonmyeloid cells than in myeloid cells. Additionally, we demonstrate that colchicine prevents speck formation and show that specks can survive in the extracellular space after cell death. Because we also found that ASC is expressed in renal glomeruli of patients with FMF but not in those of control patients, we posit that high local ASC expression may result in speck formation and that specks from dying cells may persist in the extracellular space where they have the potential (perhaps in association with pyrin) to nucleate amyloid. The fact that speck formation requires an intact microtubule network as shown here could potentially account for the ability of prophylactic colchicine to prevent or reverse amyloidosis in patients with FMF. Exp Biol Med 233:1324-1333, 2008
引用
收藏
页码:1324 / 1333
页数:10
相关论文
共 50 条
  • [1] Expression of ASC in renal tissues of IMF patients with amyloidosis; postulating a role for ASC in AA type amyloid deposition
    Balci-Peynircioglu, B.
    Waite, A.
    Schaner, P.
    Taskiran, Z.
    Richards, N.
    Orhan, D.
    Gucer, S.
    Ozen, S.
    Gumucio, D.
    Yilmaz, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (02) : 173 - 173
  • [2] Long term administration of tocilizumab improves renal amyloid A (AA) amyloidosis deposition in Familial Mediterranean fever
    Inui, Keita
    Sawa, Naoki
    Suwabe, Tatsuya
    Mizuno, Hiroki
    Yamanouchi, Masayuki
    Hiramatsu, Rikako
    Hayami, Noriko
    Hoshino, Junichi
    Kinowaki, Keiichi
    Fujii, Takeshi
    Ohashi, Kenichi
    Ubara, Yoshifumi
    MODERN RHEUMATOLOGY CASE REPORTS, 2020, 4 (02) : 310 - 311
  • [3] AMYLOID DEPOSITION IN A RENAL-TRANSPLANT IN FAMILIAL MEDITERRANEAN FEVER
    BENSON, MD
    SKINNER, M
    COHEN, AS
    ANNALS OF INTERNAL MEDICINE, 1977, 87 (01) : 31 - 34
  • [4] Identification of factors for persistence of AA amyloidosis in patients with Familial Mediterranean Fever
    Terre, Alexandre
    Savey, Lea
    Buob, David
    Grateau, Gilles
    Georgin-Lavialle, Sophie
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 108 : 128 - 130
  • [5] TOCILIZUMAB (TCZ) IN THE TREATMENT OF AA AMYLOIDOSIS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER
    Ozdogan, H.
    Ugurlu, S.
    Hacioglu, A.
    Adibnia, Y.
    Hamuryudan, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 313 - 313
  • [6] Tocilizumab in the treatment of patients with AA amyloidosis secondary to familial Mediterranean fever
    Yilmaz, Sedat
    Cinar, Muhammet
    Simsek, Ismail
    Erdem, Hakan
    Pay, Salih
    RHEUMATOLOGY, 2015, 54 (03) : 564 - 565
  • [7] Tocilizumab (TCZ) in the Treatment of AA Amyloidosis in Patients with Familial Mediterranean Fever.
    Ozdogan, Huri
    Ugurlu, Serdal
    Hacioglu, Aysa
    Adibnia, Yasaman
    Hamuryudan, Vedat
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S540 - S541
  • [8] The role of azurocidin in patients with familial Mediterranean fever and AA amyloidosis and its association with cardiovascular risk factors
    Ilter Bozaci
    Erhan Tatar
    International Urology and Nephrology, 2021, 53 : 531 - 538
  • [9] Azoospermia in familial Mediterranean fever patients: The role of colchicine and amyloidosis
    Ben-Chetrit, E
    Backenroth, R
    Haimov-Kochman, R
    Pizov, G
    ANNALS OF THE RHEUMATIC DISEASES, 1998, 57 (04) : 259 - 260
  • [10] The role of azurocidin in patients with familial Mediterranean fever and AA amyloidosis and its association with cardiovascular risk factors
    Bozaci, Ilter
    Tatar, Erhan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (03) : 531 - 538